A newfound genetic marker promises to better predict warfarin dose in African-Americans, according to a study published online in The Lancet. If confirmed in further studies, the finding may help to avert more of the bleeds and blood clots that come when a patient's starting dose misses the drug's narrow safety window.
Read more:
New genetic marker predicts warfarin dose in African-Americans
Source: News Medical
Art and Science of Laboratory Medicine
No comments:
Post a Comment